SLC41A1 and pancreatic ductal adenocarcinoma: Furthermore, SLC41A1 was reported to be downregulated in human pancreatic ductal adenocarcinoma, and SLC41A1 overexpression inhibited cell proliferation and invasion, and suppressed orthotopic tumour growth in a mouse model 10.